MORI MATTIA

Mattia
Mori
Professore Associato

Presentation

PI of a medicinal chemistry research groupthat uses advanced computational studies and biophysical methods to investigate and characterize macromolecular targets, as well as small molecules endowed with pharmacological relevance through the interaction with various types of macromolecules.

Office hours

  • Friday from 15:00 to 17:00
    Place: Da definire
    Note: E' consigliabile mandare una mail al docente per fissare appuntamento

Contacts

0577232360 [int.2360],0577232488 [int.2488] (Stanza 10 173),0577232952 [int.2952] (Stanza 10 106 San Miniato)

Curriculum Vitae

Notices

Availability of EXPERIMENTAL thesis works in computational medicinal chemistry, for students of CTF, Pharmacy, Chemical Sciences and Chemistry degree courses.

Availability of COMPILATION thesis works on topics related to medicinal chemistry and drug discovery, for students of CTF, Pharmacy, Chemical Sciences and chemistry degree courses.

For information on the topic and the timeline, please do not hesitate to contact me via email 

Teaching activities

Completion accademic year: 2026/2027

Course year: 3 Full cicle (5 years) PHARMACY A.Y. 2024/2025

Completion accademic year: 2025/2026

Course year: 3 Full cicle (5 years) PHARMACY A.Y. 2023/2024

Completion accademic year: 2024/2025

Course year: 3 Full cicle (5 years) PHARMACY A.Y. 2022/2023
Course year: 3 Full cicle (5 years) PHARMACY A.Y. 2022/2023

Completion accademic year: 2023/2024

Course year: 3 Full cicle (5 years) PHARMACY A.Y. 2021/2022
Course year: 3 Full cicle (5 years) PHARMACY A.Y. 2021/2022

Completion accademic year: 2022/2023

Course year: 4 Full cicle (5 years) PHARMACY A.Y. 2019/2020
Course year: 4 Full cicle (5 years) PHARMACY A.Y. 2019/2020

Research

Ultime pubblicazioni:

  • Bernardoni, B.L., D'Agostino, I., Siragusa, S., Mori, M., Garavaglia, S., La Motta, C. (2026). A scaffold repositioning approach: dihydroBenzoImidazoTriazineDione (BITD) derivatives as selective ALDH1A1 inhibitors. MOLECULAR DIVERSITY, 30(1), 495-508 [10.1007/s11030-025-11179-6]. - view more
  • Platella, C., Trajkovski, M., Brancaccio, M., Di Palma, R., Calcaterra, A., Mori, M., et al. (2026). Selective Delivery of Anticancer Natural G-Quadruplex Ligands by the AT11 Aptamer for Gastric Cancer Treatment. JOURNAL OF MEDICINAL CHEMISTRY, 69(1), 352-367 [10.1021/acs.jmedchem.5c02521]. - view more
  • Nocentini, A., Giovannuzzi, S., Alterio, V., Bonardi, A., Barons, R., Zalubovskis, R., et al. (2026). Discovery of a Mixed and Prodrug-Like Inhibition Mechanism for Phosphocoumarins and Phosphoquinolinones against Human Carbonic Anhydrases. JOURNAL OF MEDICINAL CHEMISTRY, 69(9), 11638-11648 [10.1021/acs.jmedchem.6c00915]. - view more
  • Cammarone, S., Pastore, V., Ryzhuk, M., Cristoferi, M., Speroni, A., Imperi, F., et al. (2026). Exploration of the aromatic abietane diterpenoid scaffold in the development of ArnT-mediated colistin resistance inhibitors. RSC ADVANCES, 16(12), 11061-11075 [10.1039/d5ra09142j]. - view more
  • Bufalieri, F., Cucinotta, A., Cammarone, S., Agnoli, F., Basili, I., Ferri, G., et al. (2026). Discovery of a new selective ERAP1 inhibitor for Hedgehog-dependent cancer treatment. MOLECULAR THERAPY, 34(1), 582-605 [10.1016/j.ymthe.2025.10.036]. - view more